Roche Holding AG

RO

Company Profile

  • Business description

    Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

  • Contact

    Grenzacherstrasse 124
    Basel4070
    CHE

    T: +41 616881111

    E: [email protected]

    https://www.roche.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    103,605

Roche Holding AG News & Analysis

stocks

6 undervalued stocks with low beta

Berkshire Hathaway and Verizon are among the low-volatility stocks that trade at a discount.
video

An undervalued, wide-moat name in healthcare

Companies racing for a coronavirus cure have moved to lofty valuations. Morningstar analyst Alex Morozov is looking for lesser-known healthcare names.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,680.5027.800.32%
CAC 407,770.9537.450.48%
DAX 4021,042.0051.690.25%
Dow JONES (US)44,025.81537.981.24%
FTSE 1008,548.2927.750.33%
HKSE19,756.47350.08-1.74%
NASDAQ19,756.78126.580.64%
Nikkei 22539,646.25618.271.58%
NZX 50 Index13,037.1415.76-0.12%
S&P 5006,049.2452.580.88%
S&P/ASX 2008,429.8027.400.33%
SSE Composite Index3,210.8531.78-0.98%

Market Movers